Background
Bone marrow (BM) mesenchymal stem cells (MSC) support proliferation and differentiation of hematopoietic progenitor cells (HPC) in vitro. Since they represent a rare subset of BM cells, MSC preparations for clinical purposes involves a preparative step of ex vivo multiplication. The aim of our study was to analyze the influence of culture duration on MSC supportive activity.
Design and Methods

MSC were expanded for up to 10 passages. MSC and CD34
+ cells were seeded in cytokinefree co-cultures after which the phenotype, clonogenic capacity and in vivo repopulating activity of harvested hematopoietic cells were assessed.
Results
Early passage MSC supported HPC expansion and differentiation toward both B lymphoid and myeloid lineages. Late passage MSC did not support HPC and myeloid cell outgrowth but maintained B cell supportive ability. In vitro maintenance of NOD/SCID mouse repopulating cells cultured for one week in contact with MSC was effective until the fourth MSC passage and declined afterwards. CD34 + cells achieved higher levels of engraftment in NOD/SCID mice when co-injected with early passage MSC; however MSC expanded beyond 9 passages were ineffective in promoting CD34 + cell engraftment. Non-contact cultures indicated that MSC supportive activity involved diffusible factors. Among these, interleukin (IL)-6 and IL-8 contributed to the supportive activity of early passage MSC but not of late passage MSC. MSC phenotype as well as fat, bone and cartilage differentiation capacity did not change during MSC culture.
Introduction
Umbilical cord blood (CB) is a valid alternative to bone marrow or mobilized peripheral blood as a source of hematopoietic stem cells (HSC) for clinical transplantation. However the use of CB HSC in adult recipients is limited by the small numbers of cells present in a single unit. Numerous studies have attempted to expand HSC ex vivo in cell cultures supplemented with various combinations of hematopoietic cytokines. Although large numbers of committed progenitors can be obtained in a short period of 7 to 10 days, expansion of true long term repopulating cells has been difficult to achieve.
MSC are non-hematopoietic cells which can typically differentiate into adipocytic, osteocytic and chondrocytic tissues. They may also participate in the formation of hematopoietic stem cell niches.
1,2 Indeed, human MSC have been reported to secrete various hematopoietic growth factors and support hematopoiesis in vitro. In cytokine-supplemented cultures of CD34 + cells together with MSC, the expansion of nucleated cells as well as colony-forming cells is increased, compared to cultures without MSC.
3 Differentiation of primitive progenitor cells occurs mainly along the myeloid lineage, but B lymphoid development has also been reported. 4, 5 In such coculture systems, repopulating cells, assayed in xenogeneic recipients, are maintained or modestly expanded.
6,7
From such studies however, the relative contribution of the cytokines and the feeder cells in the overall supportive activity has not been clearly determined. We have previously reported that SDF-1 may participate in the cell cycle-promoting activity of MSC towards co-cultured CD34 + cells.
8
Another aspect of the hematopoiesis-supporting activity of MSC lies in their ability to enhance BM homing of co-injected hematopoietic stem and progenitor cells. 9, 10 In this procedure, improved hematopoietic reconstitution can be achieved without ex vivo expansion of hematopoietic progenitors. In the NOD/SCID mouse model, BM homing is particularly enhanced when limiting numbers of CD34 + cells are infused. 11 The capacity of MSC to improve engraftment of CD34 + cells can be enhanced by stimulation with cytokines that increase CXCR4 expression by MSC.
12
Since they represent a very small fraction of BM cells, preparations of MSC for clinical purposes involves a preliminary step of ex vivo multiplication. While considerable expansion of MSC is often required to obtain large cell doses starting from a BM aspirate, the optimal duration of MSC culture has not been defined. It has recently been reported that BM homing of MSC decreases with prolonged ex vivo culture. 13 Whether other properties of MSC relevant to their hematopoiesis-supporting activity are modified ex vivo remains to be established.
14
In the present study, we analyzed the influence of culture duration on the supportive activity of MSC. The phenotype and differentiation capacity of MSC preparations was assessed after up to 10 passages. In parallel, the ability of MSC to support differentiation and self-renewal of CB hematopoietic stem/progenitor cells was assayed in cytokine-free co-cultures. Enhancement of BM homing was studied by co-transplantation of MSC and unmanipulated CB CD34 + cells in NOD/SCID mice.
Design and Methods
Cell isolation and preparation
Human BM samples were obtained from normal adult volunteers. Mononuclear cells were isolated by centrifugation over Ficoll-Paque TM Plus (GE Healthcare, Diegem, Belgium) and washed in DPBS (Lonza, Verviers, Belgium). Cells were seeded at a density of 5 x 10 5 cells/cm 2 in mesenchymal stem cell growth medium (MSCGM; Lonza). MSCGM is a ready-to-use medium supplemented with 10 % serum. Cultures were maintained in a humidified atmosphere at 37°C and 5% CO2. MSC were selected by plastic adherence and elimination of nonadherent cells 24 hours after cell seeding. When cultures reached 90% confluence, cells were detached with trypsin-EDTA solution (Lonza), and sub-cultured at 5×10 3 cells/cm 2 during ten passages. All experiments assessing the influence of passage number on the properties of MSC were done with 3 independent MSC preparations, at the exception of the secretion profile assays which were done with MSC from only 2 donors.
Human umbilical cord blood samples were obtained following full-term vaginal delivery. All samples were processed within 24 hours after delivery. Mononuclear cells were isolated by centrifugation over Ficoll-PaqueTM Plus and washed in DPBS. CD34 + cells were purified using magnetic activated cell separation (MACS) CD34 isolation kits (Miltenyi Biotech, Gladbach, Germany). The purity of selected cells was always higher than 95%.
All material was acquired with informed consent and used according to the guidelines established by the Ethical Committee of the University of Liège.
Flow cytometric analysis of MSC preparations
The following antibodies were used for phenotypic characterization of MSC: anti-CD13, anti-CD14 and anti-CD36 conjugated to fluorescein isothiocyanate (FITC), anti-CD11b, anti-CD49a, anti-CD73, anti-CD90, anti-CD106, anti-CD146, anti-CD271, anti-SSEA4 conjugated to phycoerythirn (PE) (all from BD Biosciences, Erembodegem, Belgium), PE-anti-CD105 (Serotec, Düsseldorf, Germany), PE-anti-STRO1 (Santa Cruz Biotechnology, Heidelberg, Germany), anti-CD45 (BD Biosciences), and anti-mouse IgG (Jackson ImmunoResearch, Suffolk, England) conjugated to allophycocyanin (APC), and purified anti-GD2 (BD Biosciences). Cells were incubated with antibodies or isotype-matched control IgG for 30 minutes at 4°C in the dark. Cells were washed in DPBS and fixed in DPBS 1% formaldehyde (Vel, Leuven, Belgium). Data were acquired on a BD FACSCanto II flow cytometer and analyzed by using BD FACSDiVa™ software.
MSC differentiation assays
Fat, bone and cartilage differentiation assays were carried out as described by Pittenger et al. 15 and revealed by staining with Oil Red O, Alizarin Red and Toluidine Blue, respectively. 
MSC secretion profile assays
At each passage, at 90% confluence, the medium was changed and incubated for an additional 10 days. The MSC-conditioned medium was collected and freezed at -20°C for further analyzes. In some experiments, confluent MSC were stimulated with 10 ng/ml IL-1α every other day + cells were plated either in contact with confluent MSC or in transwells seeded with MSC. Cultures were maintained during 3 weeks. Thereafter, persistence of primitive progenitors was assessed by transferring cells in a semi-solid medium to allow development of secondary hematopoietic colonies. As control, uncultured CD34 + cells were directly transferred in semisolid medium. Long term culture (LTC) medium consisted of α-MEM supplemented with 8% horse serum, 8% fetal bovine serum, 0.2 mM glutamine, 100 U/ml penicillin and 100 µg/mL streptomycin (all from Lonza), 0.2 mM inositol (Sigma-Aldrich), 0.1 mM 2-mercaptoethanol (Invitrogen, Merelbeke, Belgium). Cultures were maintained at 37°C in 5% CO2 with weekly half medium changes. In some experiments, cultures were supplemented every other day with 1 µg/mL function blocking antibodies anti-IL6 or anti-IL8 (R&D, Abingdon, UK). After 3 weeks, cultures were trypsinized. First, a third of the cell suspension was transferred in duplicate progenitor assays in a semi-solid medium consisting in MethoCult ® GF+ H4435 (Stem Cell Technologies). After an additional 2-week incubation at 37°C secondary colony-forming cells were scored. The remaining two thirds of the cells were harvested for FACS analysis. Absolute numbers of CD34 + and CD33 + cells grown in cultures were determined using TruCount tubes (BD Biosciences). APC-conjugated anti-CD34, PE-Cy7-conjugated anti-CD10, APC-Cy7-conjugated anti-CD19, PEconjugated anti-CD11b and PerCP-Cy5.5-conjugated anti-CD33 (all from BD Biosciences) were used. Cells were incubated with antibodies or isotype-matched control IgG for 30 minutes at 4°C in the dark. Cells were washed in DPBS and fixed in DPBS 1% formaldehyde. Data were acquired on a BD FACSCanto II flow cytometer and analyzed by using BD FACSDiVa™ software.
Assessment of B cell maturation
The maturation stage of B cells generated after 3 weeks of co-culture in contact with MSC was assessed by flow cytometry analysis and RT-qPCR analysis of B-specific transcripts. For FACS analysis, the following antibodies were used: FITC-conjugated anti-kappa, FITC-conjugated anti-IgM, PE-conjugated anti-lambda, PE-conjugated antiCD79a (all from BD Biosciences). After cell fixation and permeabilization with BD Cytofix/Cytoperm™ Fixation/Permeabilization kit, cells were incubated with antibodies or isotype-matched control IgG for 30 minutes at 4°C in the dark. Data were acquired on a BD FACSCanto II flow cytometer and analyzed by using BD FACSDiVa™ software.
For RT-qPCR analysis, RNA was isolated with RNeasy Blood & Tissue Kit (Qiagen, KJ Venlo, Netherlands). The RNA concentration and purity was estimated by OD measurement. To avoid genomic DNA contamination, RNA was treated with RNase-free DNaseI (Fementas GMBH, St.Leon-Rot, Germany) at 37°C for 30 minutes. cDNA synthesis were performed with RevertAid™ H Minus First Strand cDNA Synthesis Kit (Fermentas). cDNA analysis were performed by real-time PCR. Amplification was performed using the ABI Prism 7700 sequence detection system (Applied Biosystems, Lennik, Belgium). A 20 µL reaction mixture containing 10 µL of Power SYBR ® Green PCR master mix (Applied Biosystems) and cDNA template and forward and reverse primers was used. Target genes were EBF (forward primer: GATACGGCTCTGCCGCAAT, reverse primer: CAGCTGAGCCGTTGAGGAA), Pax-5 (forward primer: TGGAGGATCCAAACCAAAGG, reverse primer: GGCAAACATGGTGGGATTTT), RAG-1 (forward primer: CATCAAGCCAACCTTCGACAT, reverse primer: CAGGACCATGGACTGGATATCTC), TdT (forward primer: TTGCCCTGTTGGGATGGA, reverse primer: TCCGCTCATGTGTGGCATAG), VpreB (forward primer: GACATCGGTGTGTACAGCGTCTA, reverse primer: TGGCTCTTGTCTGATTGTGAGAA). The reference gene was β2-microglobulin (forward primer: GAGTATGCCTGCCGTGTG, reverse primer: AATCCAAATGCGGCATCT). Relative quantitations of target genes were calculated using the relative standard curve method recommended by Applied Biosystems.
Transplantation of human cells into NOD/SCID mice
Two-month old NOD/SCID mice were sublethally irradiated with 300 cGy from a 137Cs source (GammaCell 40, Nordion, Ontario, Canada). Four hours before injection, 10 days and 21 days after engraftment, the mice received 20 µL of anti asialo GM1 antiserum (Wako Chemicals GmbH, Neuss, Germany) by intraperitoneal injection. The mice received 1.5×10 5 CD34 + uncultured cells or the expansion product of 1.5×10 5 CD34 + cells cocultured for one week in contact with confluent MSC harvested at P1 to P10 in LTC medium. Other mice were transplanted with the expansion product of 1.5×10
CD34
+ cells co-cultured for one week in transwells seeded with confluent MSC. For co-transplantation experiments, mice were infused with 1.5×10 5 
Homing of MSC
Two-month old NOD/SCID mice were sublethally irradiated with 300 cGy from a 137Cs source. Four hours before injection, 10 days and 21 days after engraftment, the mice received 20 µl of anti asialo GM1 antiserum by intraperitoneal injection. Mice received 2×10 5 MSC from P3 or P7 by intravenous tail injection. After 24 hours and 5 weeks, mice were killed by cervical dislocation and blood, bone marrow, spleen, lung, liver, kidney and small intestines were harvested and frozen. Genomic DNA was isolated from mice tissues with a DNeasy Blood & Tissue Kit (Qiagen). The DNA concentration and purity was estimated by optical density (OD) measurement. DNA analyzes were performed by real-time PCR. Amplification was performed using the ABI Prism 7700 sequence detection system. A 20 µL reaction mixture containing 10 µL of Power SYBR ® Green PCR master mix and 100 ng of DNA template and forward and reverse primers was used. The target gene was human albumin, forward primer was TGAAACATACGTTCCCAAAGAGTTT , reverse primer was CTCTCCTTCTCAGAAAGTGTGCATAT. The reference gene was murine _-actin, forward primer was CCTGTGGCATCCATGAAACTAC, reverse primer was CACTGT GTTGGCATAGAGGTCTTT. Relative quantitation of human albumin gene was calculated using the comparative Ct method. A validation experiment was carried out to confirm that efficiencies of target and reference were similar. The absolute value of the slope of log input amount versus Ct was <0.1 as recommended by the manufacturer.
Statistical analysis
Results are reported as mean ± standard error of the mean (SEM). Comparisons were made using two tailed Student's t-tests, Mann-Whitney tests or Z-tests with SigmaPlot and SigmaStat softwares (SPSS, Richmond, CA, USA).
Results
MSC expansion and characterization of MSC preparations
MSC were purified by plastic adhesion and expanded in MSCGM. Cells were passaged every 10 days. The number of doublings was 2 to 3 at each passage ( Figure 1 in Online Supplementary Data). Proliferation of MSC was maintained at least up to 10 passages. Cells were harvested at each passage and assayed for phenotype and differentiation potential.
As early as the second passage, cells display a characteristic mesenchymal phenotype. Cells were negative for CD11b, CD14, CD36 and CD45. Cells were weakly positive (mean channel fluorescence ratio, MCFR 1.5 to 3.5) for CD49a, CD105, CD106 and CD146 antigens. Cells were positive (MCFR 3.5 to 9) for CD13 and CD73, and strongly positive (MCFR > 25) for CD90 and GD2 antigens. Cells did not express antigens previously reported on MSC such as CD271, SSEA4 and STRO-1 antigens 16-18 ( Figure 1 in Online Supplementary Data). There were no consistent changes in phenotype for at least 10 passages.
Differentiation into fat, bone and cartilage was assessed by transferring MSC into specific induction media 15. Lipid vacuoles, calcium deposits and chondrogenic differentiation were revealed with Oil Red O, Alizarin Red, and Toluidin Blue, respectively. The ability to differentiate into these three tissues was present in every MSC preparation tested, up to passage 10 (data not shown). All MSC preparations used to assess the hematopoiesis supportive ability as described below were confirmed to present the same phenotype and differentiation capacity.
Cytokine secretion profile
The presence of several hematopoietic cytokines, adhesion molecules and metalloproteases in MSC-conditioned medium was assayed at several passages by cytokine arrays (detection limit: 4-25 pg/mL). In baseline conditions IL-6, IL-8, SDF-1, VCAM-1, ICAM-1, MMP-2, MMP-3, MMP-13 and TIMP-4 were detected in MSCconditioned medium. When MSC were stimulated with IL1-α, an additional secretion of GM-CSF, LIF and MMP-10 was observed. Baseline and IL1-stimulated secretion profile was maintained up to passage 10 without variations in the nature of molecules detected. Next, the expression of IL-6 and IL-8, the two most abundant secreted molecules, was quantitatively measured by flow cytometric bead arrays. We observed that IL-6 secretion was at 4.95±1.27 ng/mL after 1-3 passages and increased at 24.0±8.5 after 4-6 passages (p<0.001) and was maintained until passage 10. Conversely, IL-8 secretion decreased progressively from 8.1±3.6 ng/mL after up to 3 passages, to 4.7±1.4 ng/mL after 4-6 passages, 4.3±0.7 at P7-8 and 2.3±0.6 ng/mL after 9 or 10 passages (p<0.01 vs. P1-3; Figure 1 in Online Supplementary Data 1) .
Hematopoiesis supportive ability of MSC in long term cultures
The hematopoiesis supportive ability in vitro was evaluated by establishing long-term cultures in contact and non contact conditions. In contact conditions, the output of secondary colony-forming cells (CFC) was higher after co-culture with P1 MSC and lower after co-culture with MSC harvested after ≥ 4 passages, relative to uncultured cells (p<0.05; Figure 1A ). In non contact conditions ( Figure  1B ) the number of secondary CFC was higher compared to contact conditions with all MSC preparations tested. A significant decline of hematopoiesis supportive ability with the number of passages was also noted in non contact conditions (p<0.05). The phenotype of hematopoietic cells grown in cultures with MSC was established. The expression of CD34, CD33, CD11b, CD19 and CD10 was tested on cells harvested after 3 weeks in contact and non contact conditions. Flow cytometric analysis was carried out in tubes containing a defined number of latex beads, in order to measure absolute numbers of cells with a given phenotype (Figure 2A ). In contact conditions ( Figure 2B ), an expansion of CD34 + cells was noted after culture with P2 MSC. CD34 + cell expansion was less important after culture in contact with MSC harvested after 4 passages or more (p>0.05). Myeloid cells expressing CD33 and/or CD11b also increased substantially after culture with P2 MSC, and much less with MSC of further passages (p<0.05). In contrast, lymphoid cells expressing CD19 and/or CD10 were maintained or expanded with P2 MSC as well as with P4 and P7 MSC. In non contact conditions ( Figure 2C ), CD34 + cells persisted after culture with P2, P4 or P7 MSC without net proliferation. Mature myeloid cells virtually disappeared after culture with P7 MSC (p<0.05), while lymphoid cell numbers were higher after culture with P7 MSC, as compared to P2 or P4 MSC (p<0.05). Thus, in contact and non contact conditions, MSC support for myeloid progenitors decreased with the number of passages while B lymphoid support was maintained or even increased in late passage MSC. In vitro B cell maturation of human CD34 + cells has been reported previously to be dependent on coculture with specific murine stromal cell lines, such as MS-5 and S17. 19, 20 This prompted us to investigate whether recapitulation of B cell ontogeny could be obtained with human MSC. To define the maturation stage of outgrown B cells, a phenotypical and molecular analysis was carried out. FACS analysis of cultured CD34 + cells showed the expression of cCD79a, cytoplasmic k and l light chains as well as cytoplasmic m heavy chain on > 30% of the cells. In comparison, < 4% of uncultured CD34 + expressed the same B cell markers ( Figure 3A ). Membrane expression of kappa and lambda light chains as well as complete IgM was demon- Figure 3B ). By RT-qPCR, the expression of B cell specific transcripts such as TdT, RAG, Vpreb, EBF and Pax-5 was detected in cells harvested after 3 weeks of co-culture with MSC, but not in uncultured CD34 + cells ( Figure 3C ). This indicates the induction of B cell transcriptional program in contact with MSC. Thus, CD34
+ cells undergo B cell differentiation up to the stage of immature IgM+ B cell, in contact with human MSC, similarly to previous reported models using murine stromal cell lines.
Maintenance of SCID repopulating cells in co-culture with MSC
Two-month old NOD/SCID mice sublethally irradiated with 300 cGy were used in these experiments. Cells were transplanted by intravenous tail injection. After 6 weeks mice were killed and bone marrow cells were harvested from femurs and tibias. Human chimerism was analyzed by flow cytometry ( Figure 4A ). Mice were considered positive when at least 10 cells coexpressing hCD45 and either hCD19 or hCD33 were detected in 100×10 3 mouse BM cells (detection limit: 0.01%).
First, mice received 1.5×10 5 CD34 + uncultured cells or the expansion product of 1.5×10 3 CD34 + cells co-cultured for one week with confluent MSC harvested at P1 to P10 ( Figure 4C , Table 1 Next, mice were transplanted with the expansion product of 1.5×10 5 CD34 + cells co-cultured for one week in non contact conditions, in transwells seeded with confluent P4 MSC. An additional group of mice was injected with CD34 + cells simply incubated for one week in P4 MSCconditioned medium and the last group was transplanted with CD34 + cells kept for one week in unconditioned medium ( Figure 4D , Table 1 ). The percentage of positive mice was similar when transplanted with CD34 + cells cultured in non contact conditions (72%) and in conditioned medium (80%), as compared to contact conditions (68%). There was no significant difference in the percentage of chimeric human cells between mice transplanted with CD34 + cells cultured in contact with MSC (P3-P4: 0.63±0.21%) and with MSC conditioned medium (0.56±0.32). The percentage of human cells was slightly higher after transplantation of the expansion product of CD34 + cells co-cultured in transwell (4.66±2.68%) but the difference did not reach statistical significance. Transplantation of mice with CD34 + cells cultured in unconditioned medium yielded only one positive mouse out of five, with 0.17% human chimerism. Next, we investigated the potential activity of MSC in improving bone marrow engraftment of uncultured CD34 + cells. To that effect, 1.5×10 5 fresh cord blood CD34 + cells were directly co-injected with 1.5×10 5 MSC harvested after passages 1 to 10 ( Figure 4E , Table 1 ). In this setting, more than 50% of mice showed human hematopoietic reconstitution. Compared to infusion of CD34 + cells only, the percentage of engrafted human cells was dramatically increased after co-injection with MSC harvested at P1 to P8 (p<0.006). Conversely, MSC harvested at P9 and 10 were ineffective in providing enhanced engraftment of uncultured CD34 + cells (p<0.05).
Regulation of the hematopoiesis-supportive activity of MSC by IL-6 and IL-8
We attempted to define critical cytokines contributing to the pro-hematopoietic activity of MSC. CD34 + cells were cultured in contact with MSC in medium supplemented with neutralizing antibodies anti-IL6 or IL-8, or with control IgG. First long-term cultures were established with P2 or P7 MSC as feeder cells. A decrease of CD34 + (p<0.05, Figure 5A ), CD33 + (p<0.05, Figure 5B + cells were injected alone (U) or co-injected with MSC harvested at P1 to P10 without prior culture. *p<0.01 versus other passages; **p<0.01 versus co-injection with MSC of passages P1-3, P4-6 and P7-8. Detection limit of human cell engraftment was set at 0.01% of recipient mice BM mononuclear cells.
CD19
+ (p>0.05, Figure 5C ) outgrown cells was observed after IL-6 or IL-8 neutralization in 3 weeks culture in contact with P2 MSC. Conversely, when cultures were set on P7 MSC, no effect of IL-6 neutralization was observed while increases of CD34 + and CD19+ cell outgrowth were noted after IL-8 inhibition ( Figure 5A , B and C for CD34 + cells, CD33 + cells and CD19 + cells, respectively). Next, NOD/SCID mice were transplanted with CD34 + cells cultured for one week with P2 MSC, in medium supplemented with IL-6 or IL-8 function blocking antibodies. A slight but statistically significant decrease in repopulating activity was noted after IL-8 neutralization, while IL-6 neutralization had no effect ( Figure 5D ). Thus, in contact with early passage (P2) MSC, both IL-6 and IL-8 contribute to in vitro differentiation of myeloid and lymphoid cells, while only IL-8 is involved in the maintenance of repopulating cells. Neither IL-6 nor IL-8 mediate hematopoietic support in contact with late passage (P7) MSC.
Homing of MSC
Finally, the homing capacity of MSC in several tissues was tested after passages 3 and 7. NOD/SCID mice sublethally irradiated with 300 cGy received 2×10 5 MSC from P3 or P7 by intravenous tail injection. After 24 hours and 5 weeks, mice were killed and blood, bone marrow, spleen, lung, liver, kidney and small intestine were harvested for DNA analysis by real-time PCR of human albumin. Twenty-four hours after injection of P3 MSC bone 
Discussion
Recent clinical trials indicate that MSC might be useful to prevent and/or treat graft-versus-host disease and promote donor cell engraftment after hematopoietic stem cell transplantation. 21, 22 Procedures used to prepare MSC for clinical applications are based on enrichment of MSC present in BM MNC by plastic adherence, followed by ex vivo expansion in selected serum-containing medium.
23
The duration of the ex vivo expansion step is highly variable and depends on the ratio between the number of MSC in the initial BM inoculum and the target number of MSC to infuse to the patient, i.e., on the number of doublings. It has been described that the capacity of MSC to engraft in recipient BM declines with increasing passage number. 13 Whether the hematopoiesis-supportive activity of MSC is modified with culture duration had not been studied before.
In the present study, cultures of CB CD34 + cells were set up in contact with feeder cells consisting of MSC harvested after 2 to 10 passages. Cells were plated in the absence of exogenous cytokines which might otherwise blunt changes in hemato-supportive properties of MSC. Our main results indicate a progressive decline in output of CFC by CD34 + cells cultured with MSC of increasing passage. Likewise, the outgrowth of differentiated myeloid CD33 + and CD11b + cells was reduced when MSC of late passages were used. In addition, maintenance of SRC ex vivo was reduced when MSC had executed more than 5 passages previously, which represents approximately 10 to 12 doublings. In contrast, MSC support of lymphoid CD19 + and CD10 + cell outgrowth was not dependent on the number of passages. When the engraftment-promoting activity of MSC was assayed by co-transplantation with uncultured CD34 + cells, it was also observed that late passage MSC (>9 passages or 25 doublings) were inferior compared to early passage MSC.
A detailed characterization of MSC preparations revealed only minor changes with passage number. The phenotype of MSC preparations was stable up until P10, as was the rate of doublings. Differentiation into fat, bone and cartilage was also conserved. The types of cytokines, adhesion molecules and matrix proteases detected in MSC-conditioned medium were similar in all tested passages. However, quantitative measurements of the two most abundant cytokines produced by MSC, i.e. IL-6 and IL-8, revealed a progressive decline of IL-8 secretion during culture while IL-6 secretion was increased. Inhibition experiments showed that both cytokines contributed to the outgrowth of CD34 + , CD19
+ and CD33 + cells in cultures supported by low passage MSC, but not by late passage MSC. Interestingly, IL-8 inhibition, but not of IL-6, was also associated with decreased SRC maintenance in cultures with P2 MSC. This suggests that measurement of IL-8 may represent a surrogate marker of the hemato-supportive activity of MSC, while high levels of IL-6, as observed in medium conditioned with late passage MSC, do not contribute to better support of hematopoietic cells. The mechanism by which IL-8 promotes recovery of SRC from in vitro cultures remains to be determined. IL-8 has been reported to stimulate metastasis and angiogenesis in various tumor models 24. Likewise, our hypothesis is that IL-8 enhances engraftment of repopulating cells by increasing expression of metalloprotease MMP-2 and consequently migration and infiltration within the BM 25.
Our data also indicate the influence of direct contact between MSC and CD34 + cells in co-cultures. Cultures of CD34 + cells and MSC separated in transwells by a semipermeable filter did not reduce the output of CFC and SRC, in comparison with contact cultures. In contrast, outgrowth of differentiated myeloid and lymphoid cells was massively reduced in non contact conditions. Thus, direct contact with MSC appears to be important for proliferation, late commitment and differentiation of hematopoietic cells but at the expense of a depletion of the progenitor cell compartment. From a practical standpoint for the clinical use of CD34 + cells/MSC co-cultures, non contact conditions might allow for effective CFC expansion while limiting generation of mature cells.
Our study also reveals the strong pro-lymphopoietic activity of MSC. In vitro B cell generation was previously reported to depend on specific murine stromal cell lines.
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In our study and as recently reported by Ichii et al., 4 MSC were able to support the production of B cell progenitors and immature IgM + B cells, in serum-containing medium, in the absence of exogenous cytokines. We extend these findings by showing by qPCR analysis the expression of TdT, RAG-1, VpreB, Pax-5 and EBF in outgrown B cells, but not in input CD34 + cells. Thus this coculture system recapitulate B cell ontogeny up to immature B cells and could be further used to delineate extrinsic signals implicated in human B cell development. The pro-lymphopoietic activity of MSC is not affected by prolonged ex vivo culture, up to 30 doublings. Generation of B cells by coculture of CD34 + cells and MSC opens up new therapeutic possibilities. Whether MSC co-transplantation in patients undergoing hematopoietic stem cell transplantation can be used to hasten B cell regeneration could be studied in future clinical trials. Enhancement of in vitro maturation of CD34 + cells to B lymphocytes by MSC could also have implications in the design of adoptive immunotherapy procedures.
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In conclusion, our study shows that prolonged ex vivo culture of BM MSC is associated with decreased supportive activity toward repopulating stem cells and myeloid progenitors, while the supportive activity toward B lymphoid progenitors is maintained. These changes are not accompanied by alterations in the phenotype or the dif-
